We'll discuss how this is different from other medicinal oils. We'll also break down the claims and research surrounding Rick Simpson oil and. What Is Rick Simpson Oil? Created by Canadian medical marijuana activist Rick Simpson, RSO is a cannabis-derived oil that has an especially. Table A: Populations with legal access to medicinal cannabis. 6. studies, there is little evidence of actual results in humans .. Cannabis Oil Testimonials.
Oil Rick Research Simpson Medical and
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: Cannabis use is associated with a lower prevalence of non-alcoholic fatty liver disease according to a large study. The impact of current cannabis use on general cognitive function in people with psychotic illness. No difference in cognitive abilities between people with psychosis with and without cannabis use. Intentional cannabis use to reduce crack cocaine use in a Canadian setting: The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy.
CBD may be effective in epilepsy due to brain tumours according to a case series. No significant difference between placebo and THC in the treatment of pain of patients with multiple sclerosis.
Medical Cannabis in Patients with Chronic Pain: Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson's disease. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
Cannabidiol is effective in febrile infection-related epilepsy syndrome in a case series. A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial. No differences in the number and type of adverse events were found, and no falls occurred after administration of THC.
THCV significantly decreased fasting plasma glucose and improved the function of cells in the pancreas. Effective treatment of spasticity using dronabinol in pediatric palliative care. In the majority of pediatric palliative patients the treatment with dronabinol showed promising effects in treatment resistant spasticit. Subjective aggression during alcohol and cannabis intoxication before and after aggression exposure. Subjective aggression significantly increased following aggression exposure in all groups while being sober.
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity. Dronabinol increases pain threshold in patients with functional chest pain: THC reduced pain intensity and odynophagia painful swallowing, in the mouth or oesophagus. CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience. Improvement in behaviour and alertness, language, communication, motor skills and sleep.
Following aspects significantly decreased: Migraine headache frequency on average decreased from Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Inhaled cannabis demonstrated a dose dependent reduction in peripheral treatment-refractory neuropathic pain.
Profiles of medicinal cannabis patients attending compassion centers in rhode island. Most participants report that medicinal cannabis improves their pain symptomology. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study. Smoking and Diabetes Mellitus: Experience of adjunctive cannabis use for chronic non-cancer pain: Pain patients, who receive opioids, experience better pain relief if they also take cannabis.
High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. At least daily cannabis use was associated with significant lower plasma HIV viral loads. A Single Institution Experience. THC may be very effective in the treatment of nausea and vomiting in end-stage cancer.
Nabilone did not reduce pain and nausea in patients treated for head and neck cancer. Single dose deltatetrahydrocannabinol in chronic pancreatitis patients: No effect of a single low dose of THC on abdominal pain resulting from chronic pancreatitis in clinical study.
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial. Acute effects of deltatetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
Cannabidiol in patients with treatment-resistant epilepsy: Cannabidiol reduces seizure frequency in epilepsy of children and young adults. A Phase 1a Study. A significant reduction in pain intensity was achieved after cannabis inhalation with a vaporizer. Nabiximols as an agonist replacement therapy during cannabis withdrawal: Significant improvements in pain, sleep quality and subjective evaluations of patients.
Effects of cannabidiol in the treatment of patients with Parkinson's disease: Significant improvement in well-being. No effects on motor functioning or neuroprotection. Endocannabinoids control platelet activation and limit aggregate formation under flow. Activation of cannabinoid receptors by cannabis use reduces platelet activation and blood clotting.
A positive THC screen is associated with decreased mortality in adult patients sustaining TBI [traumatic brain injury]. Safety and pharmacokinetics of oral deltatetrahydrocannabinol in healthy older subjects: A woman with intractable nausea after cerebellar stroke responded well to a treatment with THC. Nabilone caused significant improvements in insomnia, nightmares, chronic pain and other symptoms in patients suffering from posttraumatic stress disorder PTSD.
Cannabis medical marijuana treatment for motor and non-motor symptoms of Parkinson disease: Analysis of specific motor symptoms revealed significant, also sleep and pain improvement after treatment with cannabis. Using cannabis to help you sleep: Patients with high PTSD scores were more likely to use cannabis to improve sleep, and for coping reasons more generally.
THC treatment yielded a shift in EEG electroencephalogram power toward delta and theta frequencies and a strengthening of normal rhythms in the sleep.
Clinical experience with THC: CBD oromucosal spray in patients with multiple sclerosis-related spasticity. Clinical experiences with cannabinoids in spasticity management in multiple sclerosis. Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms.
A treatment with oral THC was associated with significant decreases in agitation, as well as improvements in sleep duration and appetite. A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain.
The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain. THC, which was given for 36 months, had no effect on progression compared to placebo. Objective ratings of opiate withdrawal decreased in patients using cannabis during stabilization. Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients.
In pain patients, oral dronabinol has similar psychoactive effects to smoking cannabis. The cannabis extract Sativex was generally well tolerated, with no evidence of a loss of effect for pain relief. No significant difference between placebo and Sativex in Phase A; Phase B demonstrated an analgesic effect.
Cannabis induces a clinical response in patients with Crohn's disease: Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers. Higher THC concentrations were significantly associated with less difficulty falling asleep and more daytime sleep the following day.
The medical necessity for medicinal cannabis: In an open clinical study with cancer patients all symptoms improved significantly. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: The use of cannabis did not accelerate progression to significant liver fibrosis. Impact of cannabis use during stabilization on methadone maintenance treatment. Symptoms of opiate withdrawal decrease in patients undergoing methadone maintenance treatment, who use cannabis.
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: A combination of baclofen injections into the cerebrospinal fluid and very low doses of the cannabis extract Sativex was highly effective.
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. THC dronabinol and smoked cannabis marijuana caused similar effects on pain sensitivity and pain tolerance. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. A new multiple sclerosis spasticity treatment option: The cannabis extract sativex is effective in a large number of patients and well-tolerated in the long-term.
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. Sativex appears to be a well-tolerated and useful add-on therapy in patients with spasticity due to multiple sclerosis. Less than one third of self-reported users mention a relief of their attacks following inhalation. The dose effects of short-term dronabinol oral THC maintenance in daily cannabis users. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Smoked cannabis for spasticity in multiple sclerosis: Acute effects of a single, oral dose of d9-tetrahydrocannabinol THC and cannabidiol CBD administration in healthy volunteers. Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence.
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee. Herbal cannabis use in patients labeled as fibromyalgia is associated with negative psychosocial parameters. Cannabis derivatives therapy for a seronegative stiff-person syndrome: Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
Significant improvement by the cannabis extract Cannador of spasticity and pain. Lack of effect of central nervous system-active doses of nabilone on capsaicin-induced pain and hyperalgesia. Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: Improvement in general health perception, social functioning, ability to work, physical pain and depression; weight gain; average rise in BMI; average Harvey-Bradshaw index was reduced.
A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men. Cannabis administration was associated with significant increases in plasma levels of ghrelin and leptin, and decreases in PYY, but did not significantly influence insulin levels. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Seizure exacerbation in two patients with focal epilepsy following marijuana cessation.
Patients with epilepsy were able to control their seizures by the use of cannabis. No superior analgetic effect of the synthetic cannabinoid GW over placebo.
Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: In 6 of 13 subjects blood pressure increased significantly after cessation of cannabis use. Deltatetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: Neural basis of anxiolytic effects of cannabidiol CBD in generalized social anxiety disorder: The cannabinoid receptor agonist deltatetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients.
Cannabis use in patients with fibromyalgia: The use of cannabis was associated with reduction of some fibromyalgia symptoms. Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety. Spontaneous regression of benign brain tumour may have been associated with cannabis use.
Medical cannabis use in post-traumatic stress disorder: In most cases a significant improvement in quality of life and pain, with some positive changes in severity of posttraumatic stress disorder was observed. The medicinal use of cannabis and cannabinoids: Preferred modes of use were smoking of cannabis Dronabinol reduces fasting motility of the colon in IBS patients with diarrhoea.
Dronabinol for the treatment of cannabis dependence: THC caused significant improvement in treatment retention and withdrawal symptoms. Marijuana use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV-seropositive or HIV-seronegative women. Cannabis use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV-seropositive or HIV-seronegative women.
Tetrahydrocannabinol THC for cramps in amyotrophic lateral sclerosis: There were no effects on cramp intensity, number of cramps and fasciculation intensity.
Oral Delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. Dramatic improvement of refractory Isaacs' syndrome after treatment with dronabinol. Dramathic improvement of symptoms profuse sweating, muscular twitching, weight loss. The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program.
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Cannabis was superior to placebo in reducing nausea and vomiting in patients refractory to other medications. Effect of dronabinol on central neuropathic pain after spinal cord injury: Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. In bipolar disorder subjects, cannabis use was associated with better neurocognitive function, but the opposite was the case for the schizophrenia subjects. Depression is a Major Confounding Factor. The effects of nabilone on sleep in fibromyalgia: Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia.
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Smoked medicinal cannabis for neuropathic pain in HIV: Treatment of a hyperkinetic movement disorder during pregnancy with dronabinol. Effect of Delta 9 -tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: Participants rated cannabis as similar effective as other medications for the treatment of their symptoms.
Systemic bioavailability of the cannabinoid CRA13 increased by more than 4-fold if taken together with a fat-rich meal. Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. Synthetic deltatetrahydrocannabinol dronabinol can improve the symptoms of schizophrenia. Improvement in 4 of 6 participants, of whom 3 showed a significant improvement. Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis.
White matter integrity in adolescents with histories of marijuana use and binge drinking. Brain damage was less in alcohol users who used also cannabis than in alcohol only users. Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.
A population-based case-control study of marijuana use and head and neck squamous cell carcinoma. Cannabinoid-induced effects on the nociceptive system: The study provides objective neurophysiological evidence that cannabinoids modulate the nociceptive system.
Use of medical marijuana for treatment of severe intractable nausea after laparoscopic Roux-en-Y gastric bypass surgery: Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.
Improvement of appetite and reduction of nausea and vomiting by nabilone and dronabinol THC. Adjunctive nabilone in cancer pain and symptom management: Current status of cannabis treatment of multiple sclerosis with an illustrative case presentation of a patient with MS, complex vocal tics, paroxysmal dystonia, and marijuana dependence treated with dronabinol. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation. Dramatic reduction in the severity of agitation and other behavioural symptoms.
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. Nabilone for the treatment of paraneoplastic night sweats: A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy. Similar treatment effects and side effects of cannabinoids compared to other medications. Open-label, add-on study of tetrahydrocannabinol for chronic nonmalignant pain.
A case report and review of the literature. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
A medium dose of cannabis reduced pain, while a high dose increased pain induced by capsaicin. This is in part because the medical community has been, as a whole, overly dismissive of this issue. My advice for patients is to be entirely open and honest with your physicians and to have high expectations of them. Tell them that you consider this to be part of your care and that you expect them to be educated about it, and to be able to at least point you in the direction of the information you need.
Very interesting post, may be worth noting that there is no real need for the THC element within the medical products, studies have shown that THC and CBD combined at a 1: Cbd Has been discovered to be effective for pain without the use of THC, this is one of many reasons why it hit the world market with a storm, it allowed a person to relieve themselfs at a financial cost from pain but without the psychedelic side effects of the THC.
There is a big study happening in the UK at the moment, its still relatively new but its full supported by a big company the CBD Medical and Health Research is a very good read also, based on real human subjects. The study linked above shows that THC is not needed for the effects that people look for when using CBD, it is THC that is truly illegal in most places around the world, and it is THC that is used to get a high, remove this element and the drug is far less likely to be abused, CBD is also known for helping with drug addictions and hold zero addictive properties.
Love this article and the best part is the author giving his peers advice to keep an open mind and to educate themselves so they can talk with their patients and assist them. Brian, I encourage you to keep an open mind.
Your response portrays a person bias towards cannabis. I encourage you to open your mind and so your research. Check out The Sacred Plant Docuseries. Also would you mind supplying links to back your comments on THC having no benefits as well as any resource or scientific study that shows CBD can supply the same benefits as THC. As a user and advocate of the Sacred Plant, I can share the health benefits from my own personal use.
My husband just got diagnosed with Colon cancer when this blog was posted. We are eternally grateful to have access to Cannabis and the knowledge in making his medicine.
Thank God for Rick Simpson and his oil discovery. I also look to history as our best and wisest teacher. Do you khow long Cannabis has provided medical relief benefits to millions of humans suffering.
Finally, as a believer in God knowing He created hemp and cannabis and made both for our benefit, I look forward to the much needed studies that man prevented. Man made it bad and now that millions are dying of disease man is rethinking his actions. THC does alter our thinking and for the better. Did you know cannabis consumption causes neurogenesis in adults? Did you know people have cured cancer ingesting Cannabis oil? Do you know all the ailments cannabis treats? Do you have any friends who have benefited from cannabis?
Is the CBD oil explosion a health trend or fad? How many companies will make billions selling fake CBD oil because of this fad or trend? Some questions to ponder since the media controls the marketplace. The points regarding no need for THC are not entirely accurate. Our daughter had great results using CBD oil to reduce epileptic seizures. But we saw total control by adding small doses of THC. There are methods available to minimize the issue of impairment with cannabis.
THCa, the raw component in the plant, does not get a patient high. THC needs to be decarboxylated usually by applying heat over F before it becomes psychoactive. A new powerful report published by the American National Academies of Sciences has examined the amount of research that has been published for years on the use of cannabis for medical or recreational purposes, establishing for the first time with a certain claritywhat are the positive and negative effects on proven health.
In order not to be deformed ,be informed. Overcome your lost of appetite, cure insomnia,. For your health prescriptions and medical purchases contact An. Do contact for supplies of. Feel free to contact us whenever you have a. I am 17 and have been using medical for about 2 years not smoking, just oil and making smoothies with the sun leaves and refuse to take prescription medication from the hospital, it has helped a LOT with my anxiety and depression, i cant even explain how much.
Two years ago my grandmother was diagnosed with a glioblastoma the size of a baseball, she started using the oil and started juicing to help shrink the tumor. Although this year as soon as she stopped, the cancer came right back and she is in the hospital again now. I am really confused about this study.
I read lots of article which it says Marijuana have bad effect on brain in long term and some article says opposite. Could you introduce a reliable website I can read about Marijuana more? My husband has been taking Xarelto AND Pletal as prescribed by a doctor despite pharmacists filling the prescriptions with a bit of shock and stating they should not be taken together since he had a DVT in his thigh. This happened after knee surgery in Jan , flying 13 hours in March totally unaware or warned by our doc that this was dangerous after surgery.
He was inches from death for approx 6 days and then 10 days induced coma total in ICU, 1 month in hospital recovering thankfully learning to walk again etc. Since then he has been on 10mg Xarelto night dose and mg Pletal morning dose and we have been too terrified to reduce the dose in any way even though the docs in Philippines said continue life long Xeralto and then wean off Pletal after 3 months, because the doc in Spain when we came back here said, leave it as it is.
Since then my husband and I have both lost weight. Ive lost over 40lbs and still losing as I was obese and am still overweight but its just naturally slowly coming off. They will not respond! While its legal here to use medical cannabis, the lack of knowledge by doctors here including a Dutch doctor, make it difficult to consult on the interaction and the possibility of what we desire, which is to cut down on his Xarelto and Pletal, even if its just incremental, i. This is our hope, but we are on our own as far as knowledge of the two sides i.
It will be we who decide IF to wean, which drug to wean off, or a bit of both, or all of one.. So finally to my question Whats the question? If his blood work comes back that all is ok re blood texture clotting etc, then weaning off is bad? Why the muscle loss? He has also experienced some dizziness light headed this last year which again, timing wise, ties into the addition of FECO to his diet but Im not blaming the FECO, Im hoping the FECO is acting as a blood thinner and that we can reduce the Chem meds which according to studies Ive read with tears streaming down my face, have multiple side effects.
Since the incident in Ive suffered from PTSD and my sincerest wish is to if not have closure on this, to after 5 years, adjust his medication and see some sort of forward progress in that area. The idea of him taking this the rest of his life when it may be unnecessary is horrific. We do not have access to a medical doctor who is also familiar with cannabis, so Peter I ask of you with your background and your education and family history with your grandfather, do you feel we are on the right track?
My husband seems healthy but his muscle loss over the last 7 months is dramatically visible and it frightens me him too quietly but he doesnt say much and he is tired a lot but at the same time very active.
This is an ex rugby player, full of energy who moves and is busy all day. He should not be losing muscle mass. No one can answer our questions or even nudge us in the right direction. A nudge from you would be very much appreciated.
When have we crossed a line? He needs that muscle mass to take him through the rest of his life, his muscle mass at the time of the incident in is what saved his life without doubt.. Should the same thing happen today I know I would lose him. Any thought please xx. Hi Neva, Thank you for your comment. You situation is really complicated! I would definitely consult with a Hematologist, ideally one who is comfortable with cannabis therapeutics, so they can see this issue from all sides.
This might be hard to find but hopefully you can connect with one. What about Cardiovascular effects of Marijuana? There so many different opinions and contradictions in research online i dont even know what to listen to. And because its so politically polarized with politicians and special interest Big Pharma? For example, some studies may imply cannabis causes some or other ill consequence but, if you actually read the study carefully, the cannabis and the ill consequence are just randomly associated, and have no causal relationship to each other whatsoever, and may even be caused by the same root causes.
Because I was using an oil which has to be digested unlike smoking or vaping , the effects lasted much, much longer. If you do end up taking too much my best advice is that you go lie down and just enjoy your nap while it wears off.
After realizing just how well it worked for my nausea and my steroid-induced insomnia they pumped me full of Solu-Medrol before each infusion , my interest had definitely been piqued. So I wondered, could I use cannabis oil and other cannabis products to reduce the number of prescriptions I was taking each day?
I started reading testimonials online and joining conversations about it in Facebook groups for people who used medical marijuana to help treat their MS and for those who were simply curious about trying it. As I learned more, I started experimenting with different forms, doses, and strains there are many different strains of the cannabis plant which all contain different amounts of different cannabinoids, which means each strain produces different effects to see what if any medicinal value they had.
Unfortunately for me, many of these different products did not affect me the way other people said it affected them. I have always had really bad insomnia , especially when I have to keep getting up in the middle of the night to use the restroom.
But with a little cannabis oil? I am sure many of you reading this who also suffer from insomnia and a constant urge to get up in the middle of the night to use the bathroom can imagine how much of a positive impact this alone could make on your quality of life. I have had terrible depression since my late teens and have always been on some pill for it. Because I had lived with this feeling for so long, I had become really good at hiding it behind a smile , but on the inside, the torment was still there even when on medication.
At times I may have been joking and laughing with you but in actuality, I was probably pretty miserable. After taking a small drop of oil each night for a while, I noticed that feeling was gone, and not just when the oil was actively doing its thing. I would wake up feeling fine, and my levels of stress were greatly reduced, so it became a lot easier for me to function and actually get stuff done.
Medical researchers should have full access to this stuff and be able to conduct double-blind studies like they would with any other experimental drugs that pharmaceutical companies are working on.
Because of my own experience with medical marijuana and the experiences that other people with MS have told me about, I really do feel this should be researched more and even offered as an alternative to many of the prescription medications we have all grown so familiar with, because in my experience marijuana treats a lot of the symptoms I live with ten times better than some pill. Do you use medical marijuana or hemp oil to help treat your MS?
How do you take it and what symptoms does it help? If you feel comfortable, share your experience in the comments below. Thank you for your story. I too was treated with Lemtrada alemtuzumab but when I took it the name was Campath alemtuzumab I was in a research study before it became FDA approved. I have been dosed three times since I am tired of all the pills and just looking at other avenues to try. Thanks for you honest experience.
I personally find that strains with a lot of CBG yet another cannabinoid help with any anxiety I might get with THC and reduce headaches.
Cannabis oil for epilepsy
Today, CBD is used for the treatment of a wide range of medical conditions. . In this study, 46 different cannabis oil samples were collected. What are the health benefits and risks of marijuana, also known as cannabis? Find out what the research shows. Finally, as recently recommended for clinical studies on medical cannabis, the investigators will examine the safety profile of different cannabis.